SCHEMBL5480089

SCHEMBL5480089

O=C(CNC1CCCC1)N1CCCC1

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
POLB P06746 1/20 0.59
ALDH1A1 P00352 2/20 0.57
DPP4 P27487 13/20 0.54
DPP7 Q9UHL4 7/20 0.54
FAP Q12884 6/20 0.54
MAPT P10636 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
DPP8 Q6V1X1 1/20 0.53
DPP9 Q86TI2 1/20 0.53
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5325757 0.98 KDM4E (0.61) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL29375817 0.98 KDM4E (0.61) KDM4EPOLBALDH1A1DPP4DPP7
Hydrochloric Acid SCHEMBL6175383 0.94 KDM4E (0.58) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL15780138 0.94 DPP4 (0.53) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL13716085 0.85 KDM4E (0.50) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL6823891 0.84 KDM4E (0.49) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL31702624 0.84 ALDH1A1 (0.55) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL12832457 0.84 ALDH1A1 (0.62) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL8288251 0.84 DPP4 (0.64) KDM4EPOLBALDH1A1DPP4DPP7
SCHEMBL24322523 0.81 KDM4E (0.53) KDM4EPOLBALDH1A1DPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070238753-A1 Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) MADAR DAVID J 2007-10-11 US disclosed
US-7238724-B2 Antidiabetic agents; hyperlipemic agents; obestity; immunomoderator; atherosclerosis ABBOTT LABORATORIES (US) 2007-07-03 US disclosed
US-20050215784-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2005-09-29 US disclosed
EP-1465891-A4 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARM INC (US) 2005-08-17 EP disclosed
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv GUILFORD PHARMACEUTICALS 2005-03-31 US disclosed
EP-1465891-A2 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS INC. (US) 2004-10-13 EP disclosed
WO-2003057144-A2 CHANGE INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS (US) 2003-07-17 WO disclosed
WO-2003057666-A2 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215784-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 KDM4E 1493/4885POLB 3283/4885ALDH1A1 2290/4885
US-20070238753-A1 Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 KDM4E 1493/4885POLB 3283/4885ALDH1A1 2290/4885
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv DPP4, DPP3, DPP7 KDM4E 796/4885POLB 3990/4885ALDH1A1 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.